Clin2
NCT02522611Possibly a fitNot yet recruiting

Nerve block for severe cancer bone pain

Intractable PainPalliative Care

Part of Pain clinical trials.

This study tests an experimental drug, resiniferatoxin, given as an injection near the nerves to treat severe bone pain caused by cancer that hasn't been relieved by standard treatments. The goal is to see if it can reduce pain and improve quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
30 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You have cancer that has spread to the bone, causing moderate to severe pain in your chest or lower body that hasn't been helped by usual treatments like strong painkillers.
  • You are not currently seeking or receiving treatments meant to cure your cancer (like chemotherapy or immunotherapy). Palliative treatments to relieve symptoms are okay.
  • Your average worst pain score is 6 or higher on a 0–10 scale, and you've had a test injection that temporarily reduced your pain by at least 30%.
  • You must be able to stop taking blood-thinning medications (like aspirin or Coumadin) at least 7 days before the procedure, and be willing to follow certain safety rules.
  • You must have a responsible adult to help you with daily activities through the 14-day follow-up visit, and be willing to assign a Durable Power of Attorney for research and medical care.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00804154Recruiting· Phase 1
Capsaicin-like drug for severe cancer pain

This Phase 1 trial tests a new drug related to capsaicin (resiniferatoxin) to reduce severe nerve pain from advanced cancer. It is given through a small catheter near the spinal fluid space and is meant for people whose pain medicines and other options have not worked well enough.

Bethesda, Maryland
NCT07211386Recruiting
Nerve block for severe cancer-related abdominal pain

This study tests whether a nerve block, called an erector spinae plane block, can reduce severe abdominal pain in people with gastrointestinal cancer who come to the emergency room. If you have cancer in your digestive system and are in pain that isn't controlled, this trial may help.

Philadelphia, Pennsylvania
NCT07396558Recruiting
Nerve block for lung cancer chest pain

This study tests a new way to deliver pain medicine through a small tube (catheter) placed under the skin near your back, so you can get long-lasting relief from cancer-related chest pain at home. It is for people with advanced lung cancer whose current pain treatments are not enough.

Hanoi
NCT05427058Recruiting
Nerve blocks to treat hard-to-control cancer pelvic pain

This trial tests two types of pain-relieving nerve blocks for people with severe cancer pain in the pelvis or perineum that has not improved enough with standard stepwise pain medicines. It may help reduce pain and lessen bothersome side effects from pain pills.

Malang, East Java
NCT07008703Recruiting· Phase 1/Phase 2
Study of sss40 for cancer bone pain

This trial tests a new injection called sss40 to treat moderate-to-severe pain caused by cancer that has spread to the bones. The goal is to see if it is safe and effective for people whose pain is not being controlled by current treatments.

Zhengzhou, Henan
NCT07112690Recruiting
Nerve block for radiation pain during anal cancer treatment

This study tests a nerve block procedure (ganglion impar neurolysis) to reduce severe pain caused by radiation therapy for anal or perianal skin cancer. It may help you manage pain while you continue your cancer treatment.

Atlanta, Georgia

Hear when a new Intractable Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.